Skip to main content

Table 3 Proteomic features showing significantly differences in prediction of relapse by ProteinChip in DLBCL patients.

From: Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

Mass(Da) p NR(mean) NR(SD) RE(mean) RE(SD) Fold
2954.992 0.041855 1.707398 0.795678 3.394241 1.859434 1.987961
4304.379 0.001273 9.265967 2.843153 4.905272 2.405961 0.529386
4320.266 0.030246 2.983608 1.15555 1.239195 0.72511 0.415334
5069.691 0.045795 2.972709 1.139147 1.282858 0.734228 0.431545
16093.56 0.043788 2.891461 1.049451 1.364795 0.534483 0.472009
  1. NR: Non-relapse group; RE: Relapse group; PFS: Progression free survival; Mean and SD refer to the peak intensities.
\